The plant that just outperformed two pharmaceutical hair loss drugs in a clinical trial.
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
0:00
|
6:45
From Root to Ritual by Laritelle Organic.
The plant that just outperformed two pharmaceutical hair loss drugs in – LARITELLE Skip to content Submit Close search Hair Treatments Shampoos Conditioners Sets Travel Facial Care Body Care Samples Find Your Formula Log In FREE Shipping on all US Orders laritelleproducts@gmail.com (844) 524-2572 --> Search Search Log in Or Register Hair Treatments Shampoos Conditioners Sets Travel Facial Care Bod...
Read the full article: https://laritelleorganic.com/blogs/news/the-plant-that-just-outperformed-two-pharmaceutical-hair-loss-drugs-in-a-clinical-trial
SPEAKER_00
The plant that just outperformed two pharmaceutical hair loss drugs in Laritel skip to contents. Submit Close Search Hair Treatments Shampoos Conditioners sets travel facial care body care samples. Find your formula log in free shipping on all U.S. orders. Laritel Products at gmail.com 844-524-2572. Search Search. Login or register. Hair Treatments Shampoos Conditioners sets Travel Facial Care. Body Care Samples. Find your formula. Cart Cart Zero Items. Expand Collapse. Clinical Science. Botanical Research, 6 Minutes Read. The plant that just outperformed two pharmaceutical hair loss drugs in a clinical trial. A 56-day randomized double-blind trial just published. Results for a plant-derived essence combining Centella Asiatica extracellular vesicles with IGF-1 and FGF-7 growth factors. The hair density gains were measurable, the safety profile was clean, and the mechanism it used is one botanical medicine has been working with for centuries. Laritel Olena Laritel, May 12, 2026. The most sophisticated advances in regenerative hair medicine are not moving away from plants. They are discovering, with increasing precision, exactly why plants work. Listen to this article. Spotify. In traditional Chinese medicine, it is called G. Shui Chow. In contemporary cosmetic formulation, it appears as Tintella Asiatica, an ingredient in a growing number of serums, creams, and scalp treatments that has been described by the marketing industry as a skin healing herb. A clinical trial published this year describes it differently. As a source of extracellular vesicles, nanoscale biological particles, that, combined with plant-derived growth factors, produce measurable improvements in hair density in a 56-day randomized, double-blind, placebo-controlled trial. The language of the study is not botanical, it is regenerative medicine. The plant is the same. What changed is how precisely we can now describe why it works, the science, what extracellular vesicles are, and why they matter to hair. Extracellular vesicles are nanoscale particles released by cells as part of their communication system. They carry proteins, lipids, and nucleic acids from the cell that produce them and deliver biological signals to recipient cells. In the context of hair biology, they are increasingly understood as one of the mechanisms through which stem cells instruct follicles to enter and sustain the antigen growth phase. Plant-derived extracellular vesicles, particularly those from Centella Asiatica, have been shown to carry bioactive compounds that interact with the same molecular pathways involved in hair follicle cycling. The trial published this month tested a formulation combining these vesicles with two growth F, actors that have been identified as central to follicle function, IGF-1, the growth phase activator, insulin-like growth factor 1, is one of the primary signaling molecules that promote stem cell activity in the follicle and maintains the antigen phase. Its upregulation is a documented mechanism of rosemary oil, the ingredient that matched minoxidil in a 2015 randomized trial. When IgF-1 signaling is suppressed, follicles shorten their growth cycles and begin the miniaturization process that characterizes androgenetic alopecia. The Centella Asiatica vesicle formulation includes exogenous IgF-1, the same signaling molecule that botanical actives like rosemary have been upregulating endogenously for centuries. The regenerative medicine approach and the botanical approach are, at the molecular level, working on the same target. FGF-7, the follicle cell proliferation signal, fibroblast growth factor 7, also known as keratinocyte growth factor, promotes the proliferation of follicle keratinocytes, the cells that build the hair shaft. FGF-7 is particularly active during the early antigen phase, when the follicle is establishing its growth cycle. Suppression of FGF-7 signaling is associated with shortened growth phases and reduced strand thickness. The WNTB catenin pathway, which both IGF-1 and FGF-7 interact with, is the same pathway that polygonum multiflorum was confirmed to activate in the research we covered last week. The pharmaceutical and botanical literatures uh re-increasingly describing the same molecular events, they are simply arriving at them from different directions. Centella asiatica. What the plant itself contributes beyond the growth factors it carries, the Centella asiatica extracellular vesicles deliver the plant's own bioactive compounds to the follicle, asiaticoside, metacasocide, and asiatic acid. Triterpenoids with documented anti-inflammatory, wound healing, and collagen synthesis supporting properties. These compounds reduce the follicular inflammatory environment, support the dermal sheath surrounding the follicle, and promote the tissue integrity that a healthy growth cycle requires. Ayurvedic practitioners prescribed Centella asiatica for wound healing, skin integrity, and hair health for 3,000 years before anyone identified its triterpenoid content. The observation came first. The mechanism followed. This is the pattern that botanical medicine and peer-reviewed science keep tracing together. 56 days. The trial duration. Measurable hair density improvements within two months of consistent application, three molecular pathways activated simultaneously. WNTB catinin, IGF-1, and FGF-7 signaling clean safety profile. No adverse events reported across the trial period, consistent with botanical derived formulation. The context. Why this matters beyond one trial. The significance of this research is not the specific formulation it tested, it is what that formulation represents a shift in how the most rye,